🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gregory A. Masters

Christiana Care Health System

ORCID: 0000-0002-8538-3826

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.”.

Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7006

N/A

0.584DataRank · unranked

48 citations

Jun Yin, Oudom Kour, Rebecca Teske, Wendy Stock, Kenneth Byrd +12 more

Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer

Cell Reports(2020)10.1016/j.celrep.2020.108571

N/A

0DataRank · unranked

178 citations

Fang Wang, Hui Deng, Thomas Condamine, Vinit Kumar, Michela Perego +17 more

Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway

Nature Communications(2021)10.1038/s41467-021-22033-2

N/A

0DataRank · unranked

121 citations

Emilio Sanseviero, Jun Gui, Jinyun Chen, Filippo Veglia, Qiu-Jin Yu +15 more

A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study

The Oncologist(2021)10.1002/onco.13725

N/A

0DataRank · unranked

5 citations

Zhuoxin Sun, Bonnie Ky, Jenica Upshaw, Sharyn I. Katz, Thomas J. FitzGerald +10 more

Phase 3 comparison of high-dose once-daily (QD) thoracic radiotherapy (TRT) with standard twice-daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance)/RTOG 0538.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8505

N/A

0DataRank · unranked

37 citations

Xiaofei F. Wang, Gregory A. Masters, Junheng Gao, Ritsuko Komaki, Charles Kuzma +8 more

Neoadjuvant immunotherapy in sarcomatoid mesothelioma (Alliance A082101).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps8602

N/A

0DataRank · unranked

3 citations

Xiaofei F. Wang, Dennis A. Wigle, Colleen Watt, Gregory A. Masters, Kathryn L. Kelley +3 more